GlaxoSmithKline (GSK)

Add to Watchlists

Create an Alert

41.96 -0.28 -0.66% NYSE Jul 25, 20:00 Delayed 2m USD

GlaxoSmithKline News

Wire

Headline

Time (ET)
Yahoo

Unpacking GlaxoSmithKline’s 2Q17 Revenue Expectations

07/25 18:06
Yahoo

Inside GlaxoSmithKline’s 2Q17 Earnings Estimates

07/25 16:25
Yahoo

Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK

07/25 11:18
MT Newswires

ViiV Healthcare Reports Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-Line HIV Treatment

07/25 10:13
Yahoo

GlaxoSmithKline Names Former Walmart Exec as New CTO

07/25 09:02
Yahoo

GSK hires ex-Wal-Mart executive to transform tech operations

07/25 08:08
Yahoo

Corporate News Blog - GlaxoSmithKline and Innoviva Submits EU Filing for Extended Use of Relvar Ellipta in Patients with Controlled Asthma

07/25 07:40
Yahoo

Analysts’ Recommendations for Merck in July 2017

07/25 07:35
MT Newswires

ADR Top % Movers in Pre-Market Trading

07/25 07:30
Yahoo

GSK-backed ViiV Healthcare pushing forward in HIV treatments

07/24 18:05
Yahoo

Gilead's HIV Drug Matches Glaxo Rival In Late-Stage Trials

07/24 16:45
SA Breaking News

Glaxo submits U.S. marketing application for expanded use of asthma med Arnuity Ellipta

07/24 11:25
Yahoo

The Zacks Analyst Blog Highlights: Alphabet, GlaxoSmithKline, T-Mobile, Northrop Grumman and CSX

07/24 09:30
MT Newswires

GlaxoSmithKline Submits sNDA to FDA for Arnuity Ellipta for Pediatric Asthma

07/24 09:22
MT Newswires

GlaxoSmithKline, J&J Two-Drug Combo Shows Viral Suppression Comparable To Three-Drug Regimen In HIV

07/24 06:36
Yahoo

HIV fight advances with new drug cocktails, fresh vaccine hopes

07/24 04:00
Yahoo

Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

07/21 17:01
MT Newswires

Pernix Therapeutics Warns of Lower Preliminary Q2 Revenue, Wider Loss Vs Year Ago; Commences Refinancing Transactions

07/21 16:17
SA Breaking News

FDA OKs self-injectable formulation of Glaxo's SLE med Benlysta

07/21 12:00
SA Breaking News

Glaxo submits marketing application in Europe for extended use of Relvar Ellipta

07/21 11:47

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.